Asmita Choudhury, Anuradha Ratna, Arlene Lim, Rebecca M. Sebastian, Christopher L. Moore, Aveline A. Filliol, Jacob Bledsoe, Chengkai Dai, Robert F. Schwabe, Matthew D. Shoulders, Pranoti Mandrekar – 8 August 2022 – Liver fibrosis is an aberrant wound healing response that results from chronic injury and is mediated by hepatocellular death and activation of hepatic stellate cells (HSCs). While induction of oxidative stress is well established in fibrotic livers, there is limited information on stress‐mediated mechanisms of HSC activation.

8 August 2022

8 August 2022

8 August 2022

Roberto Alva‐Ruiz, Joseph C. Ahn, Prowpanga Udompap, Luis Antonio Díaz, Juan Pablo Arab – 8 August 2022

8 August 2022

Amit G. Singal, Benjamin Haaland, Neehar D. Parikh, A. Burak Ozbay, Carol Kirshner, Shubham Chakankar, Kyle Porter, Jagpreet Chhatwal, Turgay Ayer – 8 August 2022 – Ultrasound‐based surveillance has suboptimal sensitivity for early detection of hepatocellular carcinoma (HCC) in patients with cirrhosis. There are several emerging alternatives, including a novel multitarget HCC blood test (Mt‐HBT). We compared performance of mt‐HBT against ultrasound with or without alpha‐fetoprotein (AFP) for early HCC detection in patients with cirrhosis.

8 August 2022

AASLD develops evidence-based practice guidelines and practice guidances which are updated regularly by a  multi-disciplinary panel of experts, including hepatologists, and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care.

AASLD develops evidence-based practice guidelines and practice guidances which are updated regularly by a  multi-disciplinary panel of experts, including hepatologists, and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care.